ArticleBMC cancer2024

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA.

Jennifer H Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.